[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100054002":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":18,"centralContacts":7,"locations":24,"responsibleParty":172,"collaborators":7,"id":174,"slug":175,"hasResults":176,"nctId":177,"briefTitle":178,"officialTitle":179,"acronym":7,"eligibilityCriteria":180,"healthyVolunteers":176,"sex":181,"minAge":182,"maxAge":7,"enrollmentInfo":183,"targetDuration":7,"studyType":185,"phases":186,"briefSummary":188,"conditions":189,"keywords":191,"overallStatus":199,"whyStopped":7,"lastUpdateSubmitDate":200,"lastUpdatePostDateStruct":201,"startDateStruct":7,"completionDateStruct":204,"leadSponsor":206,"locationsCount":207},{"fullName":5,"class":6},"National Institute of Allergy and Infectious Diseases (NIAID)","NIH",null,[9,12,14,16],{"type":10,"name":11,"description":7,"armGroupLabels":7,"otherNames":7},"DRUG","Indinavir sulfate",{"type":10,"name":13,"description":7,"armGroupLabels":7,"otherNames":7},"Ritonavir",{"type":10,"name":15,"description":7,"armGroupLabels":7,"otherNames":7},"Nelfinavir mesylate",{"type":10,"name":17,"description":7,"armGroupLabels":7,"otherNames":7},"Efavirenz",[19,22],{"name":20,"affiliation":7,"role":21},"Jay R. Kostman","STUDY_CHAIR",{"name":23,"affiliation":7,"role":21},"Lawrence R. Crane",[25,38,48,58,68,78,88,98,104,114,123,133,142,152,162],{"facility":26,"status":7,"city":27,"state":28,"zip":29,"country":30,"countryCode":31,"cosmosGeoPoint":32,"geoPoint":37,"contacts":7},"Community Consortium \u002F UCSF","San Francisco","California","94110","United States","US",{"type":33,"coordinates":34},"Point",[35,36],-122.41942,37.77493,{"lat":36,"lon":35},{"facility":39,"status":7,"city":40,"state":41,"zip":42,"country":30,"countryCode":31,"cosmosGeoPoint":43,"geoPoint":47,"contacts":7},"Denver CPCRA \u002F Denver Public Hlth","Denver","Colorado","802044507",{"type":33,"coordinates":44},[45,46],-104.9847,39.73915,{"lat":46,"lon":45},{"facility":49,"status":7,"city":50,"state":51,"zip":52,"country":30,"countryCode":31,"cosmosGeoPoint":53,"geoPoint":57,"contacts":7},"Washington Reg AIDS Prog \u002F Dept of Infect Dis","Washington D.C.","District of Columbia","20422",{"type":33,"coordinates":54},[55,56],-77.03637,38.89511,{"lat":56,"lon":55},{"facility":59,"status":7,"city":60,"state":61,"zip":62,"country":30,"countryCode":31,"cosmosGeoPoint":63,"geoPoint":67,"contacts":7},"AIDS Research Consortium of Atlanta","Atlanta","Georgia","303081962",{"type":33,"coordinates":64},[65,66],-84.38798,33.749,{"lat":66,"lon":65},{"facility":69,"status":7,"city":70,"state":71,"zip":72,"country":30,"countryCode":31,"cosmosGeoPoint":73,"geoPoint":77,"contacts":7},"AIDS Research Alliance - Chicago","Chicago","Illinois","60657",{"type":33,"coordinates":74},[75,76],-87.65005,41.85003,{"lat":76,"lon":75},{"facility":79,"status":7,"city":80,"state":81,"zip":82,"country":30,"countryCode":31,"cosmosGeoPoint":83,"geoPoint":87,"contacts":7},"Louisiana Comm AIDS Rsch Prog \u002F Tulane Univ Med","New Orleans","Louisiana","70112",{"type":33,"coordinates":84},[85,86],-90.07507,29.95465,{"lat":86,"lon":85},{"facility":89,"status":7,"city":90,"state":91,"zip":92,"country":30,"countryCode":31,"cosmosGeoPoint":93,"geoPoint":97,"contacts":7},"Wayne State Univ - WSU\u002FDMC \u002F Univ Hlth Ctr","Detroit","Michigan","48201",{"type":33,"coordinates":94},[95,96],-83.04575,42.33143,{"lat":96,"lon":95},{"facility":99,"status":7,"city":90,"state":91,"zip":100,"country":30,"countryCode":31,"cosmosGeoPoint":101,"geoPoint":103,"contacts":7},"Henry Ford Hosp","48202",{"type":33,"coordinates":102},[95,96],{"lat":96,"lon":95},{"facility":105,"status":7,"city":106,"state":107,"zip":108,"country":30,"countryCode":31,"cosmosGeoPoint":109,"geoPoint":113,"contacts":7},"Southern New Jersey AIDS Cln Trials \u002F Dept of Med","Camden","New Jersey","08103",{"type":33,"coordinates":110},[111,112],-75.11962,39.92595,{"lat":112,"lon":111},{"facility":115,"status":7,"city":116,"state":107,"zip":117,"country":30,"countryCode":31,"cosmosGeoPoint":118,"geoPoint":122,"contacts":7},"North Jersey Community Research Initiative","Newark","071032842",{"type":33,"coordinates":119},[120,121],-74.17237,40.73566,{"lat":121,"lon":120},{"facility":124,"status":7,"city":125,"state":126,"zip":127,"country":30,"countryCode":31,"cosmosGeoPoint":128,"geoPoint":132,"contacts":7},"Partners in Research \u002F New Mexico","Albuquerque","New Mexico","87131",{"type":33,"coordinates":129},[130,131],-106.65114,35.08449,{"lat":131,"lon":130},{"facility":134,"status":7,"city":135,"state":135,"zip":136,"country":30,"countryCode":31,"cosmosGeoPoint":137,"geoPoint":141,"contacts":7},"Harlem AIDS Treatment Grp \u002F Harlem Hosp Ctr","New York","10037",{"type":33,"coordinates":138},[139,140],-74.00597,40.71427,{"lat":140,"lon":139},{"facility":143,"status":7,"city":144,"state":145,"zip":146,"country":30,"countryCode":31,"cosmosGeoPoint":147,"geoPoint":151,"contacts":7},"The Research and Education Group","Portland","Oregon","97210",{"type":33,"coordinates":148},[149,150],-122.67621,45.52345,{"lat":150,"lon":149},{"facility":153,"status":7,"city":154,"state":155,"zip":156,"country":30,"countryCode":31,"cosmosGeoPoint":157,"geoPoint":161,"contacts":7},"Philadelphia FIGHT","Philadelphia","Pennsylvania","19107",{"type":33,"coordinates":158},[159,160],-75.16362,39.95238,{"lat":160,"lon":159},{"facility":163,"status":7,"city":164,"state":165,"zip":166,"country":30,"countryCode":31,"cosmosGeoPoint":167,"geoPoint":171,"contacts":7},"Richmond AIDS Consortium \u002F Div of Infect Diseases","Richmond","Virginia","232980049",{"type":33,"coordinates":168},[169,170],-77.46026,37.55376,{"lat":170,"lon":169},{"type":173,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100054002","a-study-of-the-effectiveness-of-different-anti-hiv-treatments-in-hiv-positive-individuals-who-have-been-on-a-protease-inhibitor-containing-drug-regimen-for-at-least-16-weeks-100054002",false,"NCT00000914","A Study of the Effectiveness of Different Anti-HIV Treatments in HIV-Positive Individuals Who Have Been on a Protease Inhibitor-Containing Drug Regimen for at Least 16 Weeks","A Randomized Study of the Virologic Efficacy of Different Antiretroviral (AR) Treatment Strategies in HIV-Infected Individuals With Detectable Plasma HIV RNA Measurements After at Least 16 Weeks on Their Initial Protease Inhibitor-Containing AR Regimens","Inclusion Criteria\n\nYou may be eligible for this study if you:\n\n* Are HIV-positive.\n* Have an HIV RNA count of at least 400 copies\u002Fml.\n* Are at least 13 years old (need consent if under 18).\n* Have been on antiretroviral treatment (including at least 2 NRTIs) for at least 16 weeks prior to study entry.\n* Agree to practice abstinence or to use effective methods of birth control, including a barrier method, during the study.\n\nExclusion Criteria\n\nYou will not be eligible for this study if you:\n\n* Are pregnant or breast-feeding.\n* Have active opportunistic (HIV-associated) infections.\n* Have taken nelfinavir (NFV) for more than 2 weeks after failing indinavir\u002Fritonavir (IDV\u002FRTV) treatment or have taken IDV\u002FRTV for more than 2 weeks after failing NFV treatment.\n* Have used any protease inhibitor other than NFV or IDV\u002FRTV for more than 2 weeks.\n* Have used any non-nucleoside reverse transcriptase inhibitor (NNRTI) for more than 1 week.","ALL","18 Years",{"count":184,"type":7},800,"INTERVENTIONAL",[187],"NA","The purpose of this study is to compare different treatments for HIV infection to see which works best to lower HIV levels and to raise the number of CD4 cells (cells of the immune system that fight infection), in HIV-positive individuals who have been on a protease inhibitor-containing drug regimen for at least 16 weeks.\n\nResearchers have found that combination anti-HIV therapy (multiple drugs given together) can help prevent AIDS-related illnesses and help people with AIDS live longer. In this study, the anti-HIV drug efavirenz (EFV) will be tested with 1 or 2 other protease inhibitors (PIs) to see which combination works best to treat HIV infection. EFV has been shown to limit the amount of HIV virus produced by infected cells.",[190],"HIV Infections",[192,193,13,194,195,196,197,198],"Drug Therapy, Combination","HIV Protease Inhibitors","Indinavir","Saquinavir","Reverse Transcriptase Inhibitors","Viral Load","Nelfinavir","COMPLETED","2021-10-27",{"date":202,"type":203},"2021-10-29","ACTUAL",{"date":205,"type":203},"2000-06",{"name":5,"class":6},15]